Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, discusses the importance of oncology practices participating in alternative payment models (APMs).
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, discusses the importance of oncology practices participating in alternative payment models (APMs).
Transcript:
What were some of the highlights from your panel on payment models?
So, I was fortunate enough to moderate a panel today on alternative payment models (APMs). We had a representative from Moffitt Cancer Center, a representative from the Memorial Healthcare System, and a representative from Florida Cancer [Specialists]. So that’s great because those are 3 very different practice settings all of whom are knee deep in APMs.
Two of the 3 are involved in the Oncology Care Model (OCM). Moffitt is not in the OCM because they’re a [prospective payment system] PPS-exempt hospital and were not allowed to participate.
But I think the take home messages were that overall the OCM has been a positive experience for the 2 groups that participated. They’ve learned a lot about how to optimize care delivery, they’ve looked at where they could improve care, they looked at the opportunities to improve the patient experience, and at the same time [were] cognizant of cost.
So, I would say one of the important takeaways was that for practices who were in the OCM, they would do it again, and that’s important. The second thing was that all 3 groups are participating in other APMs, and that is really good news. I think when the OCM was launched it was somewhat disappointing that so few commercial payers chose to participate. I was at Aetna at the time and we did choose to participate, but very few commercial payers did choose to participate.
Nonetheless, all three groups that we had on our panel today are participating in APMs, and that’s good news because I believe that the knowledge gained, for example, in the OCM is transferable to these other models, and our panelists said as much.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More